Transplantační medicína

Les associations antihypertensives en un seul comprimé: une stratégie recommandée pour l'hypertension artérielle, efficacité et observance thérapeutique.

Interdisziplinäre Patient Journey bei Asthma, CRSwNP und Typ-2-Komorbiditäten.
26. November 2026 · 18:00–20:30 Uhr

Learn why dysglycemic adults are a priority population for T1D screening.

Learn why T1D is often misclassified as T2D and how to differentiate the two in adults suspected of T1D .

Caso clínico: enfermedad arterial oclusiva crónica en el paciente diabético. Abordaje integral, metas lipídicas y manejo terapéutico.

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic, type 2 inflammatory disease that often remains uncontrolled despite standard medical and surgical treatment. According to the international EUFOREA definition, uncontrolled CRSwNP is defined by¹:

• 1. Patient-reported lack of control
• 2. Clinically relevant symptoms of active disease

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic, type 2 inflammatory disease that often remains uncontrolled despite standard medical and surgical treatment. According to the international EUFOREA definition, uncontrolled CRSwNP is defined by¹:

• 1. Patient-reported lack of control
• 2. Clinically relevant symptoms of active disease

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic, type 2 inflammatory disease that often remains uncontrolled despite standard medical and surgical treatment. According to the international EUFOREA definition, uncontrolled CRSwNP is defined by¹:

• 1. Patient-reported lack of control
• 2. Clinically relevant symptoms of active disease

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic, type 2 inflammatory disease that often remains uncontrolled despite standard medical and surgical treatment. According to the international EUFOREA definition, uncontrolled CRSwNP is defined by¹:

• 1. Patient-reported lack of control
• 2. Clinically relevant symptoms of active disease

accelRare^® is a pre-diagnosis and differential diagnosis tool. Developed, tested and validated in collaboration with 67 European rare disease specialists across multiple disciplines.

accelRare^® is a pre-diagnosis and differential diagnosis tool. Developed, tested and validated in collaboration with 67 European rare disease specialists across multiple disciplines.

accelRare^® is a pre-diagnosis and differential diagnosis tool. Developed, tested and validated in collaboration with 67 European rare disease specialists across multiple disciplines.